Orthofix International reported $446.13M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Accuray USD 292.39M 11.22M Dec/2025
AngioDynamics USD 161.35M 4.69M Sep/2025
Artivion USD 371.38M 13.86M Jun/2026
AtriCure USD 363.39M 17.86M Sep/2026
Dexcom USD 3.92B 170.6M Sep/2026
EDAP TMS EUR 50.36M 6.01M Mar/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Inogen USD 203.72M 594K Sep/2025
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Orthofix International USD 446.13M 15.39M Jun/2026
Plus Therapeutics USD 11.77M 6.26M Jun/2026
Smith & Nephew USD 4.39B 240M Jun/2026
STAAR Surgical USD 353.43M 11.08M Sep/2026
Stryker USD 14.18B 235M Sep/2026
Tandem Diabetes Care USD 820.72M 16.08M Sep/2026
Teleflex USD 1.84B 31.2M Sep/2026
Veracyte USD 467.88M 106.9M Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026